105 related articles for article (PubMed ID: 11764939)
21. High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination.
Zhirnov OP
J Med Virol; 1987 Feb; 21(2):161-7. PubMed ID: 2434613
[TBL] [Abstract][Full Text] [Related]
22. [Remantadine and 4-iodoantipyrine in the treatment and prevention of experimental influenza infection].
Evstropov AN; Iavorovskaia VE; Galegov GA
Vopr Virusol; 1989; 34(6):734-8. PubMed ID: 2483783
[No Abstract] [Full Text] [Related]
23. [Comparative study of the antiviral activity of rimantadine and bonafton].
Il'enko VI; Platonov VG; Khomenkova IK
Vopr Virusol; 1977; (2):223-8. PubMed ID: 898899
[TBL] [Abstract][Full Text] [Related]
24. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice.
Mileva M; Bakalova R; Tancheva L; Galabov A; Ribarov S
Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):1-11. PubMed ID: 11831742
[TBL] [Abstract][Full Text] [Related]
25. [Lipid peroxidation in experimental viral infection and the effect on it of interferons and alpha-tocopherol].
Ananenko AA; Malinovskaia VV; Klembovskiĭ AI; Politova LN; Pertseva NG
Vopr Med Khim; 1988; 34(6):86-9. PubMed ID: 2467439
[TBL] [Abstract][Full Text] [Related]
26. Effect of rimantadine on cytotoxic T lymphocyte responses and immunity to reinfection in mice infected with influenza A virus.
Herrmann JE; West K; Bruns M; Ennis FA
J Infect Dis; 1990 Feb; 161(2):180-4. PubMed ID: 2299203
[TBL] [Abstract][Full Text] [Related]
27. Combined protective effect of a fungal Cu/Zn-containing superoxide dismutase and rimantadine hydrochloride in experimental murine influenza a virus infection.
Serkedjieva J; Roeva I; Angelova M; Dolashka P; Voelter WG
Acta Virol; 2003; 47(1):53-6. PubMed ID: 12828346
[TBL] [Abstract][Full Text] [Related]
28. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitory action of remantadine and ribavirin on chronic influenza infection in tissue cultures].
Shobukhov VM; Galegov GA
Vopr Virusol; 1986; 31(6):734-5. PubMed ID: 3825096
[No Abstract] [Full Text] [Related]
30. Effect of vitamin E and vitamin C combination on experimental influenza virus infection.
Tantcheva LP; Stoeva ES; Galabov AS; Braykova AA; Savov VM; Mileva MM
Methods Find Exp Clin Pharmacol; 2003 May; 25(4):259-64. PubMed ID: 12808470
[TBL] [Abstract][Full Text] [Related]
31. Gastric mucosal lesions in influenza virus infected mice: role of gastric lipid peroxidation.
Mileva M; Marazova K; Galabov AS
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):521-4. PubMed ID: 14571281
[TBL] [Abstract][Full Text] [Related]
32. [Effect of remantadine on the development of toxicoses caused by different strains of influenza virus].
Kiseleva IV
Vopr Virusol; 1981; (5):541-3. PubMed ID: 7336681
[TBL] [Abstract][Full Text] [Related]
33. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection.
Savov VM; Galabov AS; Tantcheva LP; Mileva MM; Pavlova EL; Stoeva ES; Braykova AA
Exp Toxicol Pathol; 2006 Aug; 58(1):59-64. PubMed ID: 16793246
[TBL] [Abstract][Full Text] [Related]
34. [Experimental model of inhalation influenza infection for evaluation of the effectiveness of anti-influenza preparations].
D'iakov SI; Misnikov OP; Chizhov NP
Vopr Virusol; 1989; 34(6):746-9. PubMed ID: 2633469
[No Abstract] [Full Text] [Related]
35. [Activation of free radicals reaction and changes in the state of antioxidant protection in blood in toxic experimental influenza infection].
Gorbunov NV; Volgarev AP; Braĭlovskaia IV; Bykova NO; Avrova NF; Kiselev OI
Biull Eksp Biol Med; 1992 Jul; 114(7):42-4. PubMed ID: 1421305
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of the degree and spectrum of antiviral activity of 2-(1'-aminoethyl)-bicyclo[2.2.1]heptane hydrochloride].
Votiakov VI; Boreko EI; Rusiaev VA; Shashikhina MN; Kazak NF
Vopr Virusol; 1982; 27(2):172-6. PubMed ID: 7090343
[TBL] [Abstract][Full Text] [Related]
37. [Role of lipid peroxidation in the pathogenesis of influenza and search for antiviral protective agents].
Chetverikova LK; Inozemtseva LI
Vestn Ross Akad Med Nauk; 1996; (3):37-40. PubMed ID: 8672960
[TBL] [Abstract][Full Text] [Related]
38. [Protective action of remantadine in experimental influenzal-staphylococcal infection].
Medvedev ML; Koroliuk AM
Vopr Virusol; 1987; 32(5):538-40. PubMed ID: 3433711
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
[TBL] [Abstract][Full Text] [Related]
40. Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus.
Doyle WJ; Skoner DP; Alper CM; Allen G; Moody SA; Seroky JT; Hayden FG
J Infect Dis; 1998 May; 177(5):1260-5. PubMed ID: 9593010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
